Lundbeck sues IP Australia, Sandoz to escape undertaking over Lexapro licence
Intellectual Property April 9, 2019 4:44 pm By Miklos Bolza | Sydney

Global pharmaceutical giant Lundbeck has launched a bid to escape a prior undertaking blocking it from appealing a court’s decision that allowed four generic drug […]

Subscribe for instant access to all Lawyerly content. Already a subscriber? Login here. Want to test drive Lawyerly? Contact us to take a free trial.